STAAR Net Income Per E B T vs Net Income Analysis
| STAA Stock | USD 22.29 0.43 1.97% |
STAAR Surgical financial indicator trend analysis is much more than just breaking down STAAR Surgical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STAAR Surgical is a good investment. Please check the relationship between STAAR Surgical Net Income Per E B T and its Net Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.
Net Income Per E B T vs Net Income
Net Income Per E B T vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STAAR Surgical Net Income Per E B T account and Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between STAAR Surgical's Net Income Per E B T and Net Income is -0.11. Overlapping area represents the amount of variation of Net Income Per E B T that can explain the historical movement of Net Income in the same time period over historical financial statements of STAAR Surgical, assuming nothing else is changed. The correlation between historical values of STAAR Surgical's Net Income Per E B T and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income Per E B T of STAAR Surgical are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Net Income Per E B T i.e., STAAR Surgical's Net Income Per E B T and Net Income go up and down completely randomly.
Correlation Coefficient | -0.11 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Income Per E B T
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in STAAR Surgical financial statement analysis. It represents the amount of money remaining after all of STAAR Surgical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from STAAR Surgical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STAAR Surgical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.At present, STAAR Surgical's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 14.9 M, whereas Issuance Of Capital Stock is forecasted to decline to 855.00.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 179.6M | 224.6M | 258.2M | 271.1M | Cost Of Revenue | 61.0M | 69.8M | 80.2M | 84.2M |
STAAR Surgical fundamental ratios Correlations
Click cells to compare fundamentals
STAAR Surgical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
STAAR Surgical fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 257.4M | 345.8M | 415.1M | 488.7M | 562.0M | 590.1M | |
| Short Long Term Debt Total | 10.8M | 32.1M | 31.0M | 35.8M | 41.2M | 43.3M | |
| Other Current Liab | 25.0M | 30.2M | 32.6M | 36.3M | 41.7M | 43.8M | |
| Total Current Liabilities | 41.2M | 48.8M | 51.7M | 65.0M | 74.8M | 78.5M | |
| Total Stockholder Equity | 197.2M | 258.6M | 332.4M | 386.0M | 443.8M | 466.0M | |
| Property Plant And Equipment Net | 33.4M | 67.7M | 81.5M | 101.4M | 116.6M | 122.4M | |
| Net Debt | (141.7M) | (167.6M) | (55.4M) | (147.2M) | (132.5M) | (125.9M) | |
| Retained Earnings | (135.9M) | (111.4M) | (72.4M) | (47.4M) | (42.6M) | (44.8M) | |
| Cash | 152.5M | 199.7M | 86.5M | 183.0M | 210.5M | 221.0M | |
| Non Current Assets Total | 41.0M | 74.4M | 103.2M | 123.4M | 141.9M | 149.0M | |
| Non Currrent Assets Other | 608K | 822K | 957K | 3.3M | 3.0M | 1.8M | |
| Cash And Short Term Investments | 152.5M | 199.7M | 211.6M | 220.7M | 253.8M | 266.5M | |
| Net Receivables | 35.2M | 43.5M | 62.4M | 98.0M | 112.7M | 118.3M | |
| Common Stock Shares Outstanding | 48.0M | 49.5M | 49.4M | 49.4M | 56.8M | 28.8M | |
| Liabilities And Stockholders Equity | 257.4M | 345.8M | 415.1M | 488.7M | 562.0M | 590.1M | |
| Non Current Liabilities Total | 19.0M | 38.4M | 31.0M | 37.7M | 43.4M | 45.5M | |
| Inventory | 18.1M | 17.3M | 24.2M | 35.1M | 40.4M | 42.4M | |
| Other Current Assets | 10.6M | 10.9M | 9.5M | 11.4M | 13.1M | 13.8M | |
| Other Stockholder Equity | 338.2M | 373.5M | 404.2M | 436.9M | 502.5M | 527.6M | |
| Total Liab | 60.2M | 87.2M | 82.7M | 102.7M | 118.1M | 124.1M | |
| Property Plant And Equipment Gross | 33.4M | 67.7M | 81.5M | 137.2M | 157.7M | 165.6M | |
| Total Current Assets | 216.4M | 271.4M | 312.0M | 365.3M | 420.1M | 441.1M | |
| Accumulated Other Comprehensive Income | (5.5M) | (4.0M) | 156K | (4.1M) | (4.7M) | (4.5M) | |
| Short Term Debt | 7.1M | 6.8M | 3.7M | 4.4M | 5.0M | 4.5M | |
| Accounts Payable | 2.8M | 8.7M | 11.6M | 13.6M | 15.6M | 16.4M | |
| Common Stock | 464K | 477K | 482K | 488K | 561.2K | 589.3K | |
| Intangible Assets | 296K | 270K | 218K | 173K | 155.7K | 147.9K | |
| Other Liab | 8.1M | 12.4M | 9.8M | 3.6M | 4.2M | 3.8M | |
| Current Deferred Revenue | 4.5M | 4.8M | (1.3K) | 10.8M | 9.8M | 9.3M | |
| Other Assets | 4.5M | 5.6M | 4.6M | 5.8M | 6.6M | 7.0M | |
| Property Plant Equipment | 17.1M | 24.0M | 67.7M | 81.5M | 93.8M | 98.5M | |
| Net Tangible Assets | 157.8M | 195.2M | 256.6M | 330.2M | 379.8M | 398.8M | |
| Capital Lease Obligations | 9.4M | 32.1M | 31.0M | 35.8M | 41.2M | 43.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share | Quarterly Revenue Growth 0.103 | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.